iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB $176.66)
- $176.66 P/E (TTM): 20.63X Cap: $8.55B
- View IBB Profile
- View Questions on IBB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $469.21)
- $469.21 P/E (TTM): 59.62X Cap: $166.63B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $441.20)
- $441.20 P/E (TTM): 28.86X Cap: $112.26B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $208.38)
- $208.38 P/E (TTM): 88.3X Cap: $368.57B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $234.18)
- $234.18 P/E (TTM): 21.23X Cap: $564.04B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $927.03)
- $927.03 P/E (TTM): 40.39X Cap: $875.87B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $119.07)
- $119.07 P/E (TTM): 16.36X Cap: $294.25B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $176.66)
- $176.66 P/E (TTM): 20.63X Cap: $8.55B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $589.25)
- $589.25 P/E (TTM): 45.05X Cap: $46.85B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $69.29)
- $69.29 P/E (TTM): 27.39X Cap: $8.20B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $97.82)
- $97.82 P/E (TTM): 15.26X Cap: $19.46B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $26.26)
- $26.26 P/E (TTM): 15.54X Cap: $3.20B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.05)
- $28.05 P/E (TTM): 362.21X Cap: $233.87B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

iShares Biotechnology ETF (IBB $176.66)
- $176.66 P/E (TTM): 20.63X Cap: $8.55B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $138.67)
- $138.67 P/E (TTM): 17.2X Cap: $8.96B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $208.40)
- $208.40 Cap: $29.53B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $30.79)
- $30.79 P/E (TTM): 27.48X Cap: $1.20B
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $26.26)
- $26.26 P/E (TTM): 15.54X Cap: $3.20B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025

Biogen Inc. (BIIB $177.35)
- $177.35 P/E (TTM): 20.13X Cap: $26.02B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $137.64)
- $137.64 P/E (TTM): 20.33X Cap: $170.86B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $134.50)
- $134.50 P/E (TTM): 24.59X Cap: $20.43B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $208.38)
- $208.38 P/E (TTM): 88.3X Cap: $368.57B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $96.81)
- $96.81 P/E (TTM): 26.02X Cap: $168.60B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $927.03)
- $927.03 P/E (TTM): 40.39X Cap: $875.87B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $40.52)
- $40.52 P/E (TTM): 11.21X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $176.66)
- $176.66 P/E (TTM): 20.63X Cap: $8.55B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $138.67)
- $138.67 P/E (TTM): 17.2X Cap: $8.96B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $36.19)
- $36.19 P/E (TTM): 27.89X Cap: $3M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025